The first important step to clarify is the we treat patients and we do not treat images; for this reason it is important to have complete knowledge of clinical evaluation of patients with back pain and cervical and lumbar radiculopathy.
Patients will refer to interventional neuroradiologist for spine pain and we must be able to offer the best treatment available including disk treatment, facet joint treatment, vertebro-kyphoplasty or interspinous device or minimal spine device able to reduce pain. So we should be able to suggest patients the best treatment. We must understand we are not disk or vertebral "specialist" but we are minimally invasive spine specialist.
In the last 10 years many type of percutaneous disk approach came out (chemodiscolysis with chimopapain, aspiration of the nucleus according to Onik, IDET, LA-SER discectomy, nucleoplasty, etc.) and have minimized the invasive nature of surgical techniques and avoid complications like infection linked to surgery.
Chemodiscolysis with "nucleoptesis by oxygen-ozone mixture" combined with drying the nucleus with an oxygen-ozone mixture (O 2 -O 3 ) uses a colourless irritant gas with a pungent odour which is unstable and has a strong anti-oxidizing power with good antiseptic, disinfectant and antiviral properties. Ozone is prepared and administered as required by transforming a small percentage of oxygen into ozone using special generators. The O 2 -O 3 gas mixture produced can be injected into the intervertebral disc and root foramina, 3-4 ml into the disc and 15-20 ml into the neural foramen and root canal. The concentration of the mixture is adjusted by the equipment.
The dose mainly administered to treat disc disease is 30-40 micrograms/ml, a concentration calculated from experimental studies as the amount best suited to dry out the nucleus and minimize inflammation.
A number of studies have been reported in literature on the O 2 -O 3 treatment of disc herniation with satisfactory results in selected cases.
The causes of backache are the topic of scientific investigation.
Mechanical and/or inflammatory irritation of the nerve endings is responsible for low back pain
The nucleus pulposus can set off an immune-mediated inflammatory process as the proteoglycan component of its nucleus is segregated from the immune system after birth. Herniation of the nucleus pulposus would therefore trigger an autoimmune reaction, generating an inflammatory process whose cell component is mainly supported by macrophages. On the other hand, the nucleus pulposus can also give rise to an inflammatory process through a non-immune-mediated mechanism supported by the many inflammatory agents identified in its nucleus.
The reactive tissue surrounding the disc contains histiocytes, fibroblasts in the herniations, and chondrocytes in the disc protrusions able to produce cytochines (Interleukin-1 alpha, Interleukin 6 and TNF-alpha) with an increase in phospholipase A2 leading to the release of prostaglandin E2 1 , leucotrenes and thromboxanes found in larger quantities in non-contained discs herniations and patients presenting more severe symptoms. Prostaglandins cause pain. In small amounts, they enhance sensitivity of the nerve roots and other pain-producing substances like bradychinin. Experimental studies have shown that an oxygen-ozone gas mixture at the concentrations used for intradiscal treatment have the same effect as steroids on inhibiting cytochine produce and hence the pain induced by the same.
The oxygen-ozone mechanisms of action are currently being investigated and include: 1) Direct effect of ozone on the mucopolysaccharides making up the nucleus pulposus of the intervertebral disc with rupture of water molecules and shrinkage of the disc exerting compression on the nerve roots.
2) Improved microcirculation due to resolution of venous stasis and lack of oxygentated blood supply following mechanical compression of the herniated disc and disc protrusion on the vessel components.
The technical approach to the disc is the same as that used for both discography and other percutaneous intervertebral disc procedures.
In the 12 years period from 1997 to 2009, 6100 patients aged between 18 and 89 years underwent percutaneous chemodiscolysis with periradicular and pariganglionic injection of oxygen-ozone mixture in our center.
The following selection criteria were adopted for enrolment: 1) clinical: low back and/or nerve root pain resistant to previous medical treatment, physiotherapy and other therapies (manipulation, acupuncture, etc.) for a period of not less than two months 2) psychological: a firm resolve on the part of the patient to recover with a commitment to cooperate and undergo subsequent physiotherapy with postural and motor rehabilitation 3) neurological: paresthesia or hypoesthesia over the dermatome involved, mild muscle weakness and signs of root-ganglion irritation 4) neuroradiological (CT and/or MR): a) evidence of small and medium-sized herniated discs correlating with the patient's symptoms with or without degenerative disc-vertebra disease complicated by intervertebral disc changes (protrusion, herniation) b) residue of surgical (micro)-discetomy with herniation recurrence and/or hypertrophic fibrous scarring
The exclusion criteria were: 1) CT/MR evidence of a herniated disc fragment with symptoms of motor and/or sphincter disturbance 2) CT/MR evidence of disc herniation corresponding to clinically severe motor deficit and/or sphincter disturbance 3) Pregressive foot droop. The indications for O 2 -O 3 treatment were extended to FBSS patients when it was understood that the ozone mechanisms of action could be exploited to treat the chronic inflammation and venous stasis present in FBSS.
There are many and different protocols to analyze in an objective way the clinical results in patients with low back pain and HNP.
In vivo experimental studies on swine intervertebral discs and in vitro tests on human discs with intradiscal administration of an O 2 -O 3 mixture at a concentration of 27 mcg/ml demonstrated the dehydration of the fibrillary matrix of the nucleus pulposus disclosing the collagen mesh/network and regressive events (fragmentation and vacuole formation). Neoangiogenesis was sometimes present with mild hyperplasia of the chondrocytes in the matrix periphery.
Such changes are thought to be due to the decomposition of ozone with release of free radicals which act directly on the disc matrix or indirectly via proteolytic enzymes.
No early or late neurological or infectious complications have been reported following O 2 -O 3 injection. The results are virtually the same as those of other percutaneous techniques (75-80% success rate), injections can be repeated if necessary, and there are no side effects. However, the low costs of this O 2 -O 3 therapy make this the method of choice in the percutaneous treatment of herniated lumbar disc.
In our experience, intradiscal O 2 -O 3 treatment of herniated lumbar disc has revolutionized the percutaneous approach to nerve root disease making it safer, cheaper and easier to repeat than treatments currently in use. In addition, O 2 -O 3 therapy does not rule out later recourse to surgery should patients fail to benefit. The technique is also reliable and compatible with other percutaneous procedures. Our protocol include clinical and CT/MR evaluation to enroll patients, at time 0 is done the first treatment with VAS and ODS analysis, we re-evaluat patients 30 days after first treatment with VAS and ODS. If the patients recover at least 50%, we suggest a second treatment, if the patients recover 70-80%, we suggest only physical therapy, if the patient refer an improvement only of 10-20% we send him to surgeon or other therapy. O 2 -O 3 treatment also has the advantage of being feasible in virtually all patients with root syndromes without the contraindications of chemonucleolysis or nucleoaspiration which must be ruled out by discography.
On the basis of our results and the assessment of our failures, we recommend selecting patients to avoid broading the indications for treatment, thereby ensuring a high success rate.
Accurate diagnosis of the lesion and the spinal level to be treated, accurate technical execution under CT or fluoroscopic guidance in expert hands and patient follow-up by the neuroradiologist after treatment are key factors in ensuring the successful outcome of percutaneous treatment for this common condition.
